Cytotoxicity of cyclodipeptides from pseudomonas aeruginosa PAO1 leads to apoptosis in human cancer cell lines

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Vázquez Rivera, Dolores ^a   González, Omar ^a   Guzmán Rodríguez, Jaquelina ^a   Díaz Pérez, Alma L ^a   Ochoa Zarzosa, Alejandra ^a   López Bucio, José ^a   Meza Carmen, Víctor ^a   Campos García, Jesús ^a  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODIPEPTIDE DERIVATIVE; CYCLOPEPTIDE; DIPEPTIDE DERIVATIVE; LIPOCORTIN 5; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DIPEPTIDE;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CANCER CELL LINE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; NONHUMAN; PSEUDOMONAS AERUGINOSA; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; SPECIES DIFFERENCE; TUMOR CELL LINE;

ANIMALIA; EUKARYOTA; PSEUDOMONAS AERUGINOSA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CACO-2 CELLS; CELL LINE, TUMOR; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; NEOPLASMS, EXPERIMENTAL; PSEUDOMONAS AERUGINOSA; SPECIES SPECIFICITY;

EID: 84925338595     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/197608     Document Type: Article

References (29)

1. S. E. Battle, F. Meyer, J. Rello, V. L. Kung, and A. R. Hauser, "Hybrid pathogenicity island PAGI-5 contributes to the highly virulent phenotype of a Pseudomonas aeruginosa isolate in mammals," Journal of Bacteriology, vol. 190, no. 21, pp. 7130-7140, 2008.
2. P. M. de Abreu, P. G. Farías, G. S. Paiva, A. M. Almeida, and P. V. Morais, "Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard," BMC Microbiology, vol. 14, article 118, 2014.
3. C. K. Stover, X.Q. Pham, A. L. Erwin et al., "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen," Nature, vol. 406, no. 6799, pp. 959-964, 2000.
4. A. Fajardo, N. Martínez-Martín, M. Mercadillo et al., "The neglected intrinsic resistome of bacterial pathogens," PLoS ONE, vol. 3, no. 2, Article ID e1619, 2008.
5. M. B. Miller and B. L. Bassler, "Quorum sensing in bacteria," Annual Review of Microbiology, vol. 55, pp. 165-199, 2001.
6. U. Müh, B. J. Hare, B.A. Duerkop et al., "Astructurally unrelated mimic of a Pseudomonas aeruginosa acyl-homoserine lactone quorum-sensing signal," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 45, pp. 16948-16952, 2006.
7. M. T. G. Holden, S. R. Chhabra, R. de Nys et al., "Quorumsensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria," Molecular Microbiology, vol. 33, no. 6, pp. 1254-1266, 1999.
8. J. Campbell, Q. Lin, G.D. Geske, and H. E. Blackwell, "New and unexpected insights into the modulation of LuxR-type quorum sensing by cyclic dipeptides," ACS Chemical Biology, vol. 4, no. 12, pp. 1051-1059, 2009.
9. J. Seguin, M. Moutiez, Y. Li et al., "Nonribosomal peptide synthesis in animals: the cyclodipeptide synthase of Nematostella," Chemistry and Biology, vol. 18, no. 11, pp. 1362-1368, 2011.
10. L. Bonnefond, T. Arai, Y. Sakaguchi, T. Suzuki, R. Ishitani, and O. Nureki, "Structural basis for nonribosomal peptide synthesis by an aminoacyl-tRNA synthetase paralog," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 10, pp. 3912-3917, 2011.
11. S. Lautru, M. Gondry, R. Genet, and J.-L. Pernodet, "The albonoursin gene cluster of S. noursei: biosynthesis of diketopiperazine metabolites independent of nonribosomal peptide synthetases," Chemistry and Biology, vol. 9, no. 12, pp. 1355-1364, 2002.
12. R. Ortiz-Castro, C. Díaz-Pérez, M. Martínez-Trujillo, R. E. del Río, J. Campos-García, and J. López-Bucio, "Transkingdom signaling based on bacterial cyclodipeptides with auxin activity in plants," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 17, pp. 7253-7258, 2011.
13. J. E. González and N. D. Keshavan, "Messing with bacterial quorum sensing," Microbiology and Molecular Biology Reviews, vol. 70, no. 4, pp. 859-875, 2006.
14. G. Degrassi, C. Aguilar, M. Bosco, S. Zahariev, S. Pongor, and V. Venturi, "Plant growth-promoting Pseudomonas putida WCS358 produces and secretes four cyclic dipeptides: cross-talk with quorum sensing bacterial sensors," Current Microbiology, vol. 45, no. 4, pp. 250-254, 2002.
15. K. Ström, J. Sjögren, A. Broberg, and J. Schnürer, "Lactobacillus plantarumMiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid," Applied and Environmental Microbiology, vol. 68, no. 9, pp. 4322-4327, 2002.
16. X. Li, S. Dobretsov, Y. Xu, X. Xiao, O. Hung, and P.-Y. Qian, "Antifouling diketopiperazines produced by a deep-sea bacterium, Streptomyces fungicidicus," Biofouling, vol. 22, no. 3, pp. 201-208, 2006.
17. S. C. Brauns, P. Milne, R. Naudé, and M. van de Venter, "Selected cyclic dipeptides inhibit cancer cell growth and indace apoptosis in HT-29 colon cancer cells," Anticancer Research, vol. 24, no. 3, pp. 1713-1719, 2004.
18. T. Furukawa, T. Akutagawa, H. Funatani et al., "Cyclic dipeptides exhibit potency for scavenging radicals," Bioorganic & Medicinal Chemistry, vol. 20, no. 6, pp. 2002-2009, 2012.
19. M. A. Wyatt, W. Wang, C. M. Roux et al., "Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence," Science, vol. 329, no. 5989, pp. 294-296, 2010.
20. D. K. Park, K. E. Lee, C. H. Baek et al., "Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp," Journal of Bacteriology, vol. 188, no. 6, pp. 2214-2221, 2006.
21. N. Boyer, K. C. Morrison, J. Kim, P. J. Hergenrother, and M. Movassaghi, "Synthesis and anticancer activity of epipolythiodiketopiperazine alkaloids," Chemical Science, vol. 4, no. 4, pp. 1646-1657, 2013.
22. S. N. Kumar, C. Dileep, C. Mohandas, B. Nambisan, and J. Ca, "Cyclo(D-Tyr-D-Phe): a new antibacterial, anticancer, and antioxidant cyclic dipeptide from Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode," Journal of Peptide Science, vol. 20, no. 3, pp. 173-185, 2014.
23. M. K. Kwak, R. Liu, J. O. Kwon, M. K. Kim, A. H. Kim, and S. O. Kang, "Cyclic dipeptides from lactic acid bacteria inhibit proliferation of the influenza a virus," Journal of Microbiology, vol. 51, no. 6, pp. 836-843, 2013.
24. L. J. Jing, M. F. A. Bakar, M. Mohamed, and A. Rahmat, "Effect of selected Biosenbergia species on the proliferation of several cancer cell lines," Journal of Pharmacology and Toxicology, vol. 6, no. 3, pp. 272-282, 2011.
25. A. M. Nauli and S. M. Nauli, "Intestinal transport as a potential determinant of drug bioavailability," Current Clinical Pharmacology, vol. 8, no. 3, pp. 247-255, 2013.
26. S. Hong, B.-H. Moon, Y. Yong, S. Y. Shin, Y. H. Lee, and Y. Lim, "Inhibitory effect against Akt by cyclic dipeptides isolated from Bacillus sp," Journal of Microbiology and Biotechnology, vol. 18, no. 4, pp. 682-685, 2008.
27. R. Würth, F. Barbieri, and T. Florio, "New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells," BioMed Research International, vol. 2014, Article ID126586, 11 pages, 2014.
28. C. Basmadjian, Q. Zhao, E. Bentouhami et al., "Cancer wars: natural products strike back," Frontiers in Chemistry, vol. 2, article 20, 2014.
29. M. P. de Carvalho and W.-R. Abraham, "Antimicrobial and biofilm inhibiting diketopiperazines," Current Medicinal Chemistry, vol. 19, no. 21, pp. 3564-3577, 2012.